Prevention and Management of Denosumab Discontinuation Rebound Fractures

被引：1
作者：
Jain, Sumeet [1 ]
机构：
[1] Rush Univ, Med Ctr, Dept Med, Div Endocrinol, 1725 West Harrison St Suite 250, Chicago, IL 60612 USA
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2024年 / 53卷 / 04期
关键词：
Denosumab discontinuation; Rebound-associated vertebral fractures (RAVF); Denosumab withdrawal; Sequential therapy; Osteoporosis; Prolia; Delayed denosumab dose; Osteoporosis related mortality; SPONTANEOUS VERTEBRAL FRACTURES; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; BONE LOSS; CLINICAL-FEATURES; OSTEOPOROSIS; TERIPARATIDE; THERAPY; HYPERCALCEMIA; PAMIDRONATE;
D O I：
10.1016/j.ecl.2024.08.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：559 / 583
页数：25
相关论文
共 101 条
[1]   Denosumab and Mortality in a Real-World Setting: A Comparative Study [J].
Alarkawi, Dunia ;
Tran, Thach ;
Chen, Weiwen ;
March, Lyn M. ;
Blyth, Fiona M. ;
Blank, Robert D. ;
Bliuc, Dana ;
Center, Jacqueline R. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 (12) :1757-1770
[2]   Spontaneous Vertebral Fractures in Males with Osteoporosis After Denosumab Discontinuation A Report of Two Cases [J].
Anagnostis, Panagiotis ;
Paschou, Stavroula A. ;
Gonzalez-Rodriguez, Elena ;
Potoupnis, Michael ;
Tsiridis, Eleftherios ;
Lamy, Olivier ;
Goulis, Dimitrios G. .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (8S) :S581-S584
[3]   Multiple clinical vertebral fractures following denosumab discontinuation [J].
Anastasilakis, A. D. ;
Makras, P. .
OSTEOPOROSIS INTERNATIONAL, 2016, 27 (05) :1929-1930
[4]   The Five-Year Effect of a Single Zoledronate Infusion on Bone Mineral Density Following Denosumab Discontinuation in Women with Postmenopausal Osteoporosis [J].
Anastasilakis, Athanasios D. ;
Makras, Polyzois ;
Polyzos, Stergios A. ;
Papapoulos, Socrates E. .
CALCIFIED TISSUE INTERNATIONAL, 2023, 113 (04) :469-473
[5]   Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab Discontinuation [J].
Anastasilakis, Athanasios D. ;
Polyzos, Stergios A. ;
Makras, Polyzois ;
Trovas, Georgios ;
Yavropoulou, Maria P. ;
Tournis, Symeon .
JOURNAL OF CLINICAL DENSITOMETRY, 2021, 24 (04) :591-596
[6]   Progression of Rebound-Associated Vertebral Fractures Following Denosumab Discontinuation Despite Reinstitution of Treatment: Suppressing Increased Bone Turnover May Not Be Enough [J].
Anastasilakis, Athanasios D. ;
Trovas, Georgios ;
Balanika, Alexia ;
Polyzos, Stergios A. ;
Makras, Polyzois ;
Tournis, Symeon .
JOURNAL OF CLINICAL DENSITOMETRY, 2020, 24 (02) :338-340
[7]   Magnetic resonance imaging has an advantage over conventional spine X-rays in the evaluation of rebound-associated vertebral fractures following denosumab discontinuation [J].
Anastasilakis, Athanasios D. ;
Evangelatos, Gerasimos ;
Makras, Polyzois ;
Iliopoulos, Alexios .
ENDOCRINE, 2020, 69 (03) :516-518
[8]   Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial [J].
Anastasilakis, Athanasios D. ;
Papapoulos, Socrates E. ;
Polyzos, Stergios A. ;
Appelman-Dijkstra, Natasha M. ;
Makras, Polyzois .
JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 (12) :2220-2228
[9]   Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases [J].
Anastasilakis, Athanasios D. ;
Polyzos, Stergios A. ;
Makras, Polyzois ;
Aubry-Rozier, Berengere ;
Kaouri, Stella ;
Lamy, Olivier .
JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (06) :1291-1296
[10]  
[Anonymous], 2019, J Bone Miner Res, V34, pS1
12345678910